Pricing for unit-dose reintro
Has not yet been determined, DuPont Merck said. When the firm announced in October 1993 that it was discontinuing unit-dose packaging of these drugs, some customers claimed it was an effective price increase of 20 to 25 times. The move may have been an attempt by one firm to show what the effect of unitary pricing could be on the big discounts to hospitals
You may also be interested in...
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials
Specialty drug maker Shire has quietly begun scouting deals with a brand-new $50 million venture fund, the latest of several in-house investment arms to launch with their parent company's pipelines, not profits, as the measure of their worth